Collection of peripheral blood progenitor cells (PBPC) based on a rising WBC and platelet count significantly increases the number of CD34+ cells

被引:0
|
作者
MS Krieger
G Schiller
JR Berenson
K Stewart
SJ Noga
O Ballester
S Tarantolo
P Stiff
D Kuhn
E Scherzo
A Sing
C Jacobs
JM White
J DiPersio
机构
[1] CellPro Incorporated,
[2] University California,undefined
[3] Toronto Hospital,undefined
[4] Johns Hopkins University,undefined
[5] Midwestern Regional Medical Center,undefined
[6] University of Nebraska,undefined
[7] Loyola University Medical Center,undefined
[8] Washington University,undefined
来源
关键词
CD34; cell; PBSC; CD34 selection; CEPRATE SC;
D O I
暂无
中图分类号
学科分类号
摘要
The kinetics of mobilization and optimal timing of peripheral blood progenitor cell (PBPC) collection were evaluated in 190 patients with multiple myeloma undergoing stem cell harvest after mobilization with cyclophosphamide, prednisone and G-CSF. There was a strong correlation between the WBC count and the number of CD34+ cells circulating in peripheral blood (r = 0.875). Initiating leukapheresis based on rising WBC and platelet counts rather than on a fixed day increased the mean number of CD34+cells 115% (9.7 to 20.9 × 106 CD34+ cells/kg; P = 0.010) for the total of all leukaphereses and 59% for the total of all CD34-selected products (5.1 to 8.1 × 106 CD34+ cells/kg; P = 0.011). Although the yield and purity of the CD34-selected product were not significantly affected (P ⩾ 0.071), the percentage of patients with concentrations of CD34+ cells in the initial leukapheresis of >1% increased from 47% to 70% (P = 0.004). The mean purity of the selected product was related to the starting percentage: 48.9% if <1% and 81.5% if ⩾1% (P < 0.001). collection of stem cells based on rising wbc and platelet counts significantly increased the number of cd34+ cells in leukaphereses and CD34-selected products in comparison with collection on a fixed day.
引用
收藏
页码:25 / 28
页数:3
相关论文
共 50 条
  • [41] What is the optimum number of CD34+ peripheral blood stem cells for an autologous transplant?
    Jillella, AP
    Ustun, C
    STEM CELLS AND DEVELOPMENT, 2004, 13 (06) : 598 - 606
  • [42] Increased number of peripheral blood CD34+ cells in lithium-treated patients
    Ballin, A
    Lehman, D
    Sirota, P
    Litvinjuk, U
    Meytes, D
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 100 (01) : 219 - 221
  • [43] The number of CD34+ cells in the peripheral blood before leukapheresis is predictive for the volume to be processed
    deGreef, GE
    Schipperus, M
    deWinter, F
    Cornelissen, JJ
    Bontenbal, M
    vantVeer, MB
    Lowenberg, B
    BLOOD, 1996, 88 (10) : 3662 - 3662
  • [44] Targeted transduction of CD34+ hematopoietic progenitor cells in nonpurified human mobilized peripheral blood mononuclear cells
    Liang, Min
    Pariente, Nonia
    Morizono, Kouki
    Chen, Irvin S. Y.
    JOURNAL OF GENE MEDICINE, 2009, 11 (03): : 185 - 196
  • [45] Positive selection of CD34+ peripheral blood progenitor cells for autograft in patients with breast cancer
    De Rosa, L
    Pandolfi, A
    Montuoro, A
    Amodeo, R
    Pescarollo, A
    Passa, AR
    Tocci, D
    De Laurenzi, A
    BONE MARROW TRANSPLANTATION, 1998, 21 : S58 - S58
  • [46] Expansion of cord blood CD34+ 38- and CD34+ Lin-progenitor cells
    Peled, T
    Treves, A
    Nagler, A
    BONE MARROW TRANSPLANTATION, 2003, 31 : S197 - S197
  • [47] High CD34+ cell counts decrease hematological toxicity of peripheral blood progenitor cell (PBPC) transplantations
    Ketterer, N
    Salles, G
    Raba, M
    Eljaafari-Corbin, A
    Espinouse, D
    Tremisi, P
    Dumontet, C
    Moullet, I
    Neidhardt-Berard, EM
    Bouafia, F
    Coiffier, B
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 204 - 204
  • [48] Rosuvastatin Increases the Relative Number of CD34+/KDR+ but not CD34+/CD133+Endothelial Progenitor Cells in Elderly Hypercholesterolemic Patients.
    Iturry-Yamamoto, German
    Machado, Denise
    Bruscato, Neide
    Vieira, Jose
    Moriguchi, Emilio
    CIRCULATION, 2010, 122 (02) : E27 - E27
  • [49] Minimal number of circulating CD34+ cells to ensure successful leukapheresis and engraftment in autologous peripheral blood progenitor cell transplantation
    Pérez-Simón, JA
    Caballero, MD
    Corral, M
    Nieto, MJ
    Orfao, A
    Vazquez, L
    Amigo, ML
    Berges, C
    González, M
    Del Cañizo, C
    San Miguel, JF
    TRANSFUSION, 1998, 38 (04) : 385 - 391
  • [50] Hematopoietic recovery in cancer patients after transplantation of autologous peripheral blood CD34+ cells or unmanipulated peripheral blood stem and progenitor cells
    Beguin, Y
    Baudoux, E
    Sautois, B
    Fraipont, V
    Schaaf-Lafontaine, N
    Pereira, M
    Paulus, JM
    Sondag, D
    Fillet, G
    TRANSFUSION, 1998, 38 (02) : 199 - 208